| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 205448-64-2 | Methyl 4-(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)-2-methoxybenzoate | C16H17NO7 |
| 205448-65-3 | 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxylic acid methyl ester | C12H11NO4 |
| 205448-66-4 | 4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester | C12H10ClNO3 |
| 205451-26-9 | Methyl O-beta-D-glucopyranosyl-(1$rarr$4)-S-beta-D-glucopyranosyl-(1$rarr$4)-O-4-thio-beta-D-glucopyranosyl-(1$rarr$4)-beta-D-glucopyranoside | C25H44O20S |
| 205485-24-1 | 3-(3-Methoxyphenyl)-3-(trifluoromethyl)diazirine | C9H7F3N2O |
| 205485-25-2 | 2-Methoxy-4-[3-(trifluoromethyl)-3H-diazirin-3-yl]benzaldehyde | C10H7F3N2O2 |
| 205495-66-5 | (1S,2S)-(-)-N,N'-Bis(2-diphenylphosphino-1-napthoyl)-1,2-diaminocyclohexane | C52H44N2O2P2 |
| 205502-58-5 | Tumor rejection antigen (human 9-amino acid fragment) | C56H66N10O15S |
| 205517-34-6 | (R)-N,N'-Bis(p-methoxybenzyl)-3-isopropyl-piperazine-2,5-dione | C23H28N2O4 |
| 205518-89-4 | 2-Ethylpyrimidine-5-carbaldehyde | C7H8N2O |
| 205524-46-5 | D-Pyroglutamic acid tert-butyl ester | C9H15NO3 |
| 205524-47-6 | Boc-D-Pyroglutamic acid tere-butyl ester | C14H23NO5 |
| 205524-62-5 | (2R)-2-Amino-4-bromobutanoic acid | C4H8BrNO2 |
| 205526-22-3 | Fmoc-2-chloro-D-phenylalanine | C24H20ClNO4 |
| 205526-23-4 | Fmoc-3-chloro-D-phenylalanine | C24H20ClNO4 |
| 205526-24-5 | Fmoc-3,5-difluoro-L-phenylalanine | C24H19F2NO4 |
| 205526-26-7 | Fmoc-2-fluoro-L-phenylalanine | C24H20FNO4 |
| 205526-27-8 | Fmoc-L-3-Trifluoromethylphenylalanine | C25H20F3NO4 |
| 205526-28-9 | Fmoc-D-3-Trifluoromethylphenylalanine | C25H20F3NO4 |
| 205526-29-0 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-4-iodo-D-phenylalanine | C24H20INO4 |
| 205526-31-4 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-3,4,5-trifluoro-D-phenylalanine | C24H18F3NO4 |
| 205526-32-5 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2,3,4,5,6-pentafluoro-L-phenylalanine | C24H16F5NO4 |
| 205526-34-7 | Fmoc-D-4-Cyanophenylalanine | C25H20N2O4 |
| 205526-36-9 | Fmoc-L-3-cyanophenylalanine | C25H20N2O4 |
| 205526-37-0 | Fmoc-D-3-cyanophenylalanine | C25H20N2O4 |
| 205526-38-1 | N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-4,4'-biphenylalanine | C30H25NO4 |
| 205526-39-2 | Fmoc-L-2-indanyglycine | C26H23NO4 |
| 205528-30-9 | Fmoc-3-(4-pyridyl)-D-alanine | C23H20N2O4 |
| 205528-32-1 | (alphaS)-alpha-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-thiazolepropanoic acid | C21H18N2O4S |
| 205528-33-2 | Fmoc-D-3-(4-Thiazoyl)alanine | C21H18N2O4S |
| 205534-17-4 | 2",4"-Di-O-(Z-p-coumaroyl)afzelin | C39H32O14 |
| 205582-81-6 | 2,3:4,5-Bis-O-(1-methylethylidene)-alpha-D-psicopyranose | C12H20O6 |
| 205584-69-6 | 4,6-Dichloro-7-methoxyquinazoline | C9H6Cl2N2O |
| 205640-90-0 | Orexin A (human) | C152H243N47O44S4 |
| 205645-02-9 | SPD 502 | C24H27N4O7S.Na |
| 205650-69-7 | Fipronil amide | C12H6Cl2F6N4O2S |
| 205652-98-8 | 3-Amino-5-nitrobenzoic acid hydrazide | C7H8N4O3 |
| 205654-80-4 | (2R,4S)-2,4-Diphenyl-5-oxooxazolidine-3-carboxylic acid benzyl ester | C23H19NO4 |
| 205672-19-1 | 4-Benzyloxy-5-bromo-2-chloropyrimidine | C11H8BrClN2O |
| 205672-25-9 | 4-Amino-5-bromo-2-chloropyrimidine | C4H3BrClN3 |
| 205683-34-7 | 2,4-Dibromo-6-fluorobenzaldehyde | C7H3Br2FO |
| 205687-01-0 | Capsiate | C18H26O4 |
| 205687-03-2 | Dihydrocapsiate | C18H28O4 |
| 205688-52-4 | 5-Amino-2H-3,1-benzoxazine-2,4(1H)-dione | C8H6N2O3 |
| 205692-63-3 | 2,5-Pyrazinedicarboxylic acid dihydrate | C6H4N2O4.2(H2O) |
| 205692-64-4 | 5-methyl-4-oxo-3-Piperidinecarboxylic acid methyl ester hydrochloride | C8H13NO3.HCl |
| 205744-14-5 | (2-Chloropyridin-3-yl)methanamine | C6H7ClN2 |
| 205744-17-8 | 2-Fluoro-5-(aminomethyl)pyridine | C6H7FN2 |
| 205744-18-9 | 6-Fluoro-2-Pyridinemethanamine | C6H7FN2 |
| 205744-92-9 | 2-[2-[2-Chloro-3-[(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl]ethenyl]-1,3,3-trimethyl-3H-indolium salt with 4-methylbenzenesulfonic acid | C32H36ClN2.C7H7O3S |